about
ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancerA systems biology approach to characterize the regulatory networks leading to trabectedin resistance in an in vitro model of myxoid liposarcomaCD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cellsIdentification of novel vascular markers through gene expression profiling of tumor-derived endothelium.Interpretation of expression-profiling results obtained from different platforms and tissue sources: examples using prostate cancer data.Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effectPARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models.Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.A promoter-proximal transcript targeted by genetic polymorphism controls E-cadherin silencing in human cancers.Wiring miRNAs to pathways: a topological approach to integrate miRNA and mRNA expression profilesiASPP/p63 autoregulatory feedback loop is required for the homeostasis of stratified epithelia.Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues.Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation.Regulation of aromatase expression in breast cancer treated with anastrozole neoadjuvant therapy.The FoxO3a gene is a key negative target of canonical Notch signalling in the keratinocyte UVB response.p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis.Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient.Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression.MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression.Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer.Preclinical activity of EGFR and MEK1/2 inhibitors in the treatment of biliary tract carcinoma.Multifactorial ERβ and NOTCH1 control of squamous differentiation and cancer.Current understanding of the thrombospondin-1 interactome.Altered molecular pathways in melanocytic lesions.Gene and microRNA modulation upon trabectedin treatment in a human intrahepatic cholangiocarcinoma paired patient derived xenograft and cell line.A novel Nrf2-miR-29-desmocollin-2 axis regulates desmosome function in keratinocytes.ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression.Resveratrol inhibits IL-6-induced ovarian cancer cell migration through epigenetic up-regulation of autophagy.The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression.Targeting of the adaptor protein Tab2 as a novel approach to revert tamoxifen resistance in breast cancer cells.Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents.Eps8 involvement in neuregulin1-ErbB4 mediated migration in the neuronal progenitor cell line ST14A.Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity.Reduced expression and tumor suppressor function of the ETS transcription factor ESE-3 in prostate cancer.Molecular characterisation of two human cancer cell lines selected in vitro for their chemotherapeutic drug resistance to ET-743.Cross-analysis of gene and miRNA genome-wide expression profiles in human fibroblasts at different stages of transformation.A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells.Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2.Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer.
P50
Q21091136-BDBC183E-1D41-4727-B11D-CB75750E6BF3Q28482357-756A989D-DB15-44D2-B5DF-BEDCCE635631Q30484805-A8E39300-6DD0-4DA5-8A55-FFE8580F6765Q30843102-B5CA4D5D-A2EB-4D48-B4F3-C3E557B24438Q30976001-85D36CAC-504F-414B-B5D8-FDF5C339B270Q33302426-4F1E3D9D-4DDC-48F7-959C-4FC9B11570D8Q33617922-8D093F7E-F1D1-4BA9-9578-A13FA98AAB3DQ33750719-D268F17C-5EA5-4AB2-9C42-08C904D49DB0Q33766602-8D1462B9-1A4B-43C9-8DFD-A655A3EB69E9Q33791204-CD4F27CF-23CD-45E0-B602-EC1E941BC698Q34214054-D0FAC521-C6E2-4DD3-99DB-B7FE41FE9A45Q34428112-FE657F95-6D7E-4137-AF09-840B6D8F2012Q35921330-7BC42507-2333-4D6E-BD54-F15ED18A9C8EQ36603917-9A006021-DA34-4F6E-9120-7C1DBD9A8D06Q36632589-4E62221B-4E9B-4BC5-BD67-F65B880D464AQ36694173-5935C6B5-3188-4AFF-A48D-4F514D7ED0D1Q36834539-D250BE15-F09F-4AE6-882A-DE6F5BBB3CF3Q37109753-DAECB96B-4F0A-4209-8A3A-018405144AD3Q37452209-A80CC4A1-2492-4582-B0B9-C33BD450D831Q37565364-26635AD8-C8C4-4D85-9907-2EB663D803B6Q37588461-4AF6A793-C852-4BB9-B386-3E21944B6080Q37728495-81DAA07F-04C8-4365-B9A6-14E1D7105FA9Q38183216-319D752B-290B-47C9-8BAE-64A9A2581B39Q38508830-872FA615-3141-4494-9FBE-B2A848567E21Q38728270-61F253C7-7D62-4679-B34B-77BEA4ADEFA5Q38950505-9C48979A-BB99-4EA1-A62A-4769D605459BQ39149787-92848AEE-D29C-4DEA-9DDB-531D58972833Q39243827-1713233D-C46E-491A-8401-63A38CDA3180Q39397231-0ADA1800-E2A7-48C4-AF4C-03E5590F91F0Q39411427-E32518CE-DC89-464B-8E7A-F5EBF71C06C9Q39497253-BEE0E1E5-62CE-476F-8199-7F0515A48875Q39600239-CA3DAB21-DD73-4318-80D3-D0C898DD1003Q39930338-001EC4E4-0DAC-4016-B908-C60A1FCD605AQ40044894-677E81E3-96FE-4E30-953E-087220A8CE1FQ40468426-E36BA66B-F2C5-4C3D-9B3F-8E5AD0945B43Q40963795-59EDE4CE-4855-4464-A70A-6B7AA03C1278Q41039911-A6346916-3F33-45AE-BA73-59649BBD86D8Q41862341-3FD81BA5-B593-4AF4-867B-04E2430FE8EAQ42835129-44587895-D340-4B5E-9FC0-8F75ABC06B8DQ43080802-40CE7E18-4099-4985-B83C-D2966CE6522F
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Giovanna Chiorino
@an
Giovanna Chiorino
@ast
Giovanna Chiorino
@ca
Giovanna Chiorino
@da
Giovanna Chiorino
@de
Giovanna Chiorino
@en
Giovanna Chiorino
@es
Giovanna Chiorino
@eu
Giovanna Chiorino
@fr
Giovanna Chiorino
@gl
type
label
Giovanna Chiorino
@an
Giovanna Chiorino
@ast
Giovanna Chiorino
@ca
Giovanna Chiorino
@da
Giovanna Chiorino
@de
Giovanna Chiorino
@en
Giovanna Chiorino
@es
Giovanna Chiorino
@eu
Giovanna Chiorino
@fr
Giovanna Chiorino
@gl
prefLabel
Giovanna Chiorino
@an
Giovanna Chiorino
@ast
Giovanna Chiorino
@ca
Giovanna Chiorino
@da
Giovanna Chiorino
@de
Giovanna Chiorino
@en
Giovanna Chiorino
@es
Giovanna Chiorino
@eu
Giovanna Chiorino
@fr
Giovanna Chiorino
@gl
P1053
K-5037-2016
P106
P1153
6603464587
P21
P31
P3829
P496
0000-0002-9502-6400